Envoy Medical, Inc. financial data

Symbol
COCH, COCHW on Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
4875 White Bear Parkway, White Bear Lake, Minnesota
Fiscal year end
December 31
Former names
Anzu Special Acquisition Corp I (to 9/29/2023)
Latest financial report
10-Q - Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 99 % +523%
Debt-to-equity -127 % -69.9%
Return On Equity 185 % +130%
Return On Assets -111 % -821%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.6 M shares
Common Stock, Shares, Outstanding 19.5 M shares
Entity Public Float 44.2 M USD -89.4%
Weighted Average Number of Shares Outstanding, Basic 19.6 M shares +93.6%
Weighted Average Number of Shares Outstanding, Diluted 19.6 M shares +93.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 59 K USD -24.4%
Research and Development Expense 2.36 M USD +22.5%
Selling and Marketing Expense 325 K USD -12.4%
General and Administrative Expense 2.12 M USD +54%
Costs and Expenses 4.96 M USD +28.8%
Operating Income (Loss) -19.5 M USD -77.5%
Nonoperating Income (Expense) -1.37 M USD +85.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 5.62 M USD -132%
Income Tax Expense (Benefit) 2.36 M USD +11.9%
Net Income (Loss) Attributable to Parent -22.9 M USD +16%
Earnings Per Share, Basic -0.32 USD/shares +75.6%
Earnings Per Share, Diluted -0.32 USD/shares +75.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.22 M USD +2205%
Accounts Receivable, after Allowance for Credit Loss, Current 189 K USD
Inventory, Net 1.46 M USD
Assets, Current 7.73 M USD +1395%
Property, Plant and Equipment, Net 317 K USD
Assets 8.48 M USD -81.5%
Accounts Payable, Current 913 K USD -41.7%
Accrued Liabilities, Current 5.62 M USD +1.36%
Liabilities, Current 7 M USD -26.3%
Other Liabilities, Noncurrent 127 K USD
Liabilities 15.9 M USD -24.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -119 K USD
Retained Earnings (Accumulated Deficit) -265 M USD -1278%
Stockholders' Equity Attributable to Parent -7.41 M USD +84.4%
Liabilities and Equity 8.48 M USD -81.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.85 M USD -94.2%
Net Cash Provided by (Used in) Financing Activities 6.68 M USD +67.1%
Net Cash Provided by (Used in) Investing Activities -109 K USD -84.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 727 K USD -21.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.95 M USD +344%
Deferred Tax Assets, Valuation Allowance 5.78 M USD +796%
Deferred Tax Assets, Gross 50.2 M USD +13.1%
Operating Lease, Liability 535 K USD
Depreciation 34 K USD +25.9%
Payments to Acquire Property, Plant, and Equipment 59 K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -6.27 M USD +52.7%
Lessee, Operating Lease, Liability, to be Paid 543 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 155 K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 154 K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 99 K USD
Deferred Tax Assets, Operating Loss Carryforwards 41.2 M USD +2.13%
Preferred Stock, Shares Issued 100 M shares
Preferred Stock, Shares Authorized 1 M shares 0%
Unrecognized Tax Benefits 516 K USD -5.32%
Lessee, Operating Lease, Liability, to be Paid, Year Four 99 K USD
Additional Paid in Capital 258 M USD
Preferred Stock, Shares Outstanding 4.5 M shares
Deferred Tax Assets, Net of Valuation Allowance 50.2 M USD +13.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%